GeneDx Holdings (WGS) Inventory (2020 - 2026)

GeneDx Holdings has disclosed Inventory across 7 years of filings, most recently posting $12.2 million for Q1 2026.

• In Q1 2026, Inventory fell 3.32% year-over-year to $12.2 million; the TTM figure through Mar 2026 stood at $12.2 million (down 3.32% YoY), while the FY2025 annual figure was $14.0 million, up 31.0% from the prior year.
• Inventory retreated to $12.2 million in Q1 2026, from $14.0 million in the prior quarter.
• Over the last five years, Inventory for WGS reached as high as $44.2 million in Q3 2022 and fell as low as $8.8 million in Q4 2023.
• The 5-year median for Inventory is $11.9 million (2025), against an average of $16.6 million.
• Annual changes were most pronounced in 2022 — Inventory surged 42.82% — and 2023, when it sank 78.84%.
• A 5-year view of Inventory shows it stood at $13.7 million in 2022, then tumbled by 35.77% to $8.8 million in 2023, then grew by 21.34% to $10.6 million in 2024, then jumped by 31.0% to $14.0 million in 2025, then retreated by 12.26% to $12.2 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $12.2 million, $14.0 million, and $10.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.